Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.05

-0.6%

Dec 9 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Arthur Radley	2/22/2005 9:05:20 AM
	Read Replies (2) of 52153

LGND: This is my favorite love/hate stock of all time. I've held a small core position in this stock for about 5 years, plus I've traded in and out of it numerous times. I think the management of this company doesn't have a clue as to how to run a biotech,however, could all the "promise" finally be ready to "knock" on the door of being a winner? From this recent news release it appears that it will be make or break time for Targretin for non-small cell lung cancer in about mid-March. biz.yahoo.com I would like a show of hands from you mavens as to what the odds of this being a positive event for LGND..or will it result in Robinson merely saying that LGND will be profitable next year..next year...next year!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next